ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Coronavirus

Food poisoning kit transforms into 10-minute coronavirus test

Nippon Sheet Glass readies lightweight device priced below competing exam kits

Nippon Sheet Glass converted a test kit designed to detect microbial contamination in food. (Photo by Megumi Iwano)

TOKYO -- Japan's Nippon Sheet Glass has converted a kit used to prevent food poisoning outbreaks into a diagnostic test for the novel coronavirus capable of returning results in as little as 10 minutes.

The company, which plans to put the portable kit on sale as soon as July, will use a lower price of roughly 800,000 yen ($7,460) per unit to compete against the legion of rival products entering the market.

"It's much cheaper than rival products, which sell for between 2 million yen and 10 million yen," said a representative for the company.

Nippon Sheet Glass has developed a compact gene analyzer that uses the polymerase chain reaction technique to determine the DNA of microorganisms. The analyzer is used primarily to identify microbial contamination in food, among other sanitary applications. The device has been sold on a pilot basis since last year.

The testing kit is under review by an expert body to gauge its performance. If it passes muster, Nippon Sheet Glass will sell the device in Israel and elsewhere overseas, then market the product domestically by the end of the year.

PCR diagnostic tests for COVID-19 use mucus taken from the back of the nose or saliva to replicate genetic material to ascertain the presence of the coronavirus. The Japanese company's device can yield results in 10 to 15 minutes.

Nippon Sheet Glass looks to expand its catalog of PCR testing kits by developing new devices, such as those to check water quality in the home and the office. These devices will be as small as smartphones, and priced at no more than 200,000 yen.

The company aims to make 45 billion yen from its PCR testing kits in fiscal 2026, up from 200 million yen in the financial year ended in March.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media